SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kallmann, B A
Right arrow Articles by Reiners, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kallmann, B A
Right arrow Articles by Reiners, K
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Disabilities
*Multiple Sclerosis
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis

B A Kallmann

Department of Neurology, Universitätsklinikum der Bayerischen Julius-Maximilians-Universität, 97080 Würzburg, Germany, kallmann_b{at}klinik.uni-wuerzburg.de

S Fackelmann

Department of Neurology, Universitätsklinikum der Bayerischen Julius-Maximilians-Universität, 97080 Würzburg, Germany

K V Toyka

Department of Neurology, Universitätsklinikum der Bayerischen Julius-Maximilians-Universität, 97080 Würzburg, Germany

P Rieckmann

Department of Neurology, Universitätsklinikum der Bayerischen Julius-Maximilians-Universität, 97080 Würzburg, Germany

K Reiners

Department of Neurology, Universitätsklinikum der Bayerischen Julius-Maximilians-Universität, 97080 Würzburg, Germany

Evoked potentials (EP) have a role in making the diagnosis of multiple sclerosis (MS) but their implication for predicting the future disease course in MS is under debate. EP data of 94 MS patients examined at first presentation, and after five and ten years were retrospectively analysed. Patients were divided into two groups in relation to the prior duration of disease at the time point of first examination: group 1 patients (n-44) were first examined within two years after disease onset, and group 2 patients (n-50) at later time points. As primary measures sum scores were calculated for abnormalities of single and combined EP (visual (VEP), somatosensory (SEP), magnetic motor evoked potentials (MEP)). In patients examined early after disease onset (group 1), a significant predictive value for abnormal EP was found with MEP and SEP sum scores at first presentation correlating significantly with Expanded Disability Status Scale (EDSS) values after five years, while the VEP sum score was not. The cumulative number of abnormal MEP, SEP and VEP results also indicated higher degrees of disability (EDSS≥ 3.5) after five years. Combined pathological SEP and MEP findings at first presentation best predicted clinical disability (EDSS≥ 3.5) after five years (odds ratio 11.0). EP data and EDSS at first presentation were not significantly linked suggesting that EP abnormalities at least in part represented clinically silent lesions not mirrored by EDSS. For patients in later disease phases (group 2), no significant associations between EP data at first presentation and EDSS at five and ten years were detected. Together with clinical findings and MR imaging, combined EP data may help to identify patients at high risk of long-term clinical deterioration and guide decisions as to immunomodulatory treatment.

Key Words: evoked potentials • multiple sclerosis • predictors of disability

Multiple Sclerosis, Vol. 12, No. 1, 58-65 (2006)
DOI: 10.1191/135248506ms1244oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
P Jung, A Beyerle, and U Ziemann
Multimodal evoked potentials measure and predict disability progression in early relapsing-remitting multiple sclerosis
Multiple Sclerosis, May 1, 2008; 14(4): 553 - 556.
[Abstract] [PDF]


Home page
Mult SclerHome page
M. Simo, P. Barsi, and Z. Aranyi
Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria
Multiple Sclerosis, May 1, 2008; 14(4): 472 - 478.
[Abstract] [PDF]


Home page
Mult SclerHome page
B Casanova, I Bosca, S Parra, A Pascual, and F Coret
Letter to the Editor
Multiple Sclerosis, August 1, 2006; 12(4): 521 - 522.
[PDF]



Advertisement